Themis Medicare Share Price

Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more. As of 25 May 2026, Themis Medicare share price is ₹100.90. The stock opened at ₹101.99, compared to its previous close of ₹100.29. During today's trading session, Themis Medicare share price moved in the range of ₹99.42 to ₹101.99, with an average price of ₹100.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹99.42 and a high of ₹101.99. On the performance front, Themis Medicare share price has declined by 7.75% over the last six months and is down 28.69% on a year-on-year basis.

The market capitalization of Themis Medicare is ₹927 Crs, with a P/E ratio of -53.2 and a dividend yield of 0.50%.